Individual risk prediction of anticoagulation in atrial fibrillation patients with cirrhosis

被引：0
|
作者：
Kim, I. [1 ]
Lee, H. W. [2 ]
Kim, B. K. [2 ]
Seo, J. W. [1 ]
Min, P. K. [1 ]
Choi, E. Y. [1 ]
Yoon, Y. W. [1 ]
Lee, B. K. [1 ]
Hong, B. K. [1 ]
Rim, S. J. [1 ]
Kwon, H. M. [1 ]
Kim, J. Y. [1 ]
机构：
[1] Yonsei Univ, Gangnam Severance Hosp, Seoul, South Korea
[2] Severance Hosp, Internal Med, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Anticoagulation for Atrial Fibrillation in Patients With Cancer
    Yasui, Taku
    Fujita, Masashi
    CIRCULATION JOURNAL, 2022, 86 (02) : 211 - 212
  • [32] WARFARIN IN PATIENTS WITH LIVER CIRRHOSIS AND ATRIAL FIBRILLATION WORTH THE RISK?
    Grewal, Harpreet
    Dangayach, Neha
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [33] Risk factors for underuse of anticoagulation in frail elderly patients with atrial fibrillation
    Dalleur, O.
    Maes, F.
    Henrard, S.
    Wouters, D.
    Scavee, C.
    Spinewine, A.
    Boland, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 875 - 875
  • [34] Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
    Carlisle, Matthew A.
    Shrader, Peter
    Fudim, Marat
    Pieper, Karen S.
    Blanco, Rosalia G.
    Fonarow, Gregg C.
    Naccarelli, Gerald V.
    Gersh, Bernard J.
    Reiffel, James A.
    Kowey, Peter R.
    Steinberg, Benjamin A.
    Freeman, James V.
    Ezekowitz, Michael D.
    Singer, Daniel E.
    Allen, Larry A.
    Chan, Paul S.
    Pokorney, Sean D.
    Peterson, Eric D.
    Piccini, Jonathan P.
    HEART RHYTHM O2, 2022, 3 (06): : 621 - 628
  • [35] Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls
    Garwood, Candice L.
    Corbett, Tia L.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (04) : 523 - 532
  • [36] Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer
    O'Neal, Wesley T.
    Claxton, J'Neka S.
    Sandesara, Pratik B.
    MacLehose, Richard F.
    Chen, Lin Y.
    Bengtson, Lindsay G. S.
    Chamberlain, Alanna M.
    Norby, Faye L.
    Lutsey, Pamela L.
    Alonso, Alvaro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : 1913 - 1922
  • [37] Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation - The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Borowsky, LH
    Henault, LE
    Chang, YC
    Selby, JV
    Singer, DE
    CIRCULATION, 2000, 102 (01) : 11 - 13
  • [38] Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review
    Wan, Yi
    Heneghan, Carl
    Perera, Rafael
    Roberts, Nia
    Hollowell, Jennifer
    Glasziou, Paul
    Bankhead, Clare
    Xu, Yongyong
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (02): : 84 - 91
  • [39] The impact of anticoagulation intensity on severity of stroke in atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Hylek, EM
    Go, AS
    Chang, YC
    Phillips, KA
    Henault, LE
    Capra, AM
    Jensvold, NG
    Selby, JV
    Singer, DE
    CIRCULATION, 2002, 106 (19) : 577 - 578
  • [40] Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis
    Chokesuwattanaskul, Ronpichai
    Thongprayoon, Charat
    Bathini, Tarun
    Torres-Ortiz, Aldo
    O'Corragain, Oisin A.
    Watthanasuntorn, Kanramon
    Lertjitbanjong, Ploypin
    Sharma, Konika
    Preechawat, Somchai
    Ungprasert, Patompong
    Kroner, Paul T.
    Wijarnpreecha, Karn
    Cheungpasitporn, Wisit
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (04) : 489 - 495
12345